Dolby Laboratories, Inc.

  • Market Cap: Small Cap
  • Industry: Software Products
  • ISIN: US25659T1079
USD
66.07
-0.22 (-0.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Dolby Laboratories, Inc. stock-summary
stock-summary
Dolby Laboratories, Inc.
Software Products
Dolby Laboratories, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration. Its technologies include Advanced Audio Coding and High Efficiency Advanced Audio Coding, Dolby AC-4, Dolby Atmos, Dolby Digital, Dolby Digital Plus, Dolby TrueHD, Dolby Vision, Dolby Voice and High Efficiency Video Coding. It distributes its products in over 80 countries. Its technologies are incorporated in offerings in various end markets, such as the broadcast, Personal Computer, mobile, consumer electronics and other markets.
Company Coordinates stock-summary
Company Details
1275 Market St , SAN FRANCISCO CA : 94103-1410
stock-summary
Tel: 1 415 55802001 415 6455583
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 102 Schemes (50.84%)

Foreign Institutions

Held by 196 Foreign Institutions (13.36%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Peter Gotcher
Independent Chairman of the Board
Mr. Kevin Yeaman
President, Chief Executive Officer, Director
Ms. Micheline Chau
Independent Director
Mr. David Dolby
Independent Director
Mr. N. William Jasper
Independent Director
Mr. Simon Segars
Independent Director
Mr. Roger Siboni
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
316 Million
(Quarterly Results - Jun 2025)
Net Profit:
47 Million
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 7,024 Million (Small Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.80%

stock-summary
Debt Equity

-0.29

stock-summary
Return on Equity

10.42%

stock-summary
Price to Book

2.70